Company Info
Phone(214) 492-0506
Year Established
1981
Ticker
RGEN
Exchange
NASDAQ
Contacts
Tony J. HuntCEO
James R. Bylund
COO
Jason K. Garland
CFO
Ralf Kuriyel
Senior VP, R&D
Olivier Loeillot
President & CEO
Kola Otitoju
Senior VP, Business Development
Company Description
Repligen develops and manufactures products for the biopharmaceutical industry under an ISO 9001 quality management system.